PBI-4050 cleared to commence trials in patients with diabetic kidney disease Nov. 12, 2014 No Comments
FDA and Health Canada permit expanded access administration of Tekmira's TKM-Ebola Sep. 23, 2014 No Comments
Antibe Therapeutics receives Canadian clearance to begin phase I program for ATB-346 June 23, 2014 No Comments